Fig. 6From: RETRACTED ARTICLE: Inhibition of human liver cancer cell growth by evodiamine involves apoptosis and deactivation of PI3K/AKT pathwayEvodiamine inhibits the invasion of the liver cancer cells. Transwell invasion assay was executed to monitor HepG2 and PLHC-1 cells invasion ability following evodiamine treatment. Results showed that invasiveness of HepG2 and PLHC-1 cells was suppressed upon evodiamine treatment. The experiments were performed in triplicate and expressed as mean ± SD (*P < 0.05)Back to article page